INDOMETHACIN
INDOMETHACIN is a pharmaceutical drug with 81 clinical trials. Currently 4 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 48 completed trials
Phase Distribution
Phase Distribution
23
Early Stage
13
Mid Stage
33
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
48 of 64 finished
25.0%
16 ended early
4
trials recruiting
81
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Saccharomyces Boulardii CNCM I-745 on Intestinal Barrier Function
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
Clinical Trials (81)
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Saccharomyces Boulardii CNCM I-745 on Intestinal Barrier Function
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
Sex-Specific Cerebrovascular Dysfunction in Metabolic Syndrome-Role of COX
Treatment of Orthostatic Intolerance
Single-dose Prophylactic INdomethacin in Extremely Preterm Infants
Brain Blood Flow Responses to Stress: Sex Differences
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis
Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus
Trial of Indomethacin in Chronic Pancreatitis
Canadian National PDA Treatment Study
IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis
Early Treatment Versus Expectative Management of PDA in Preterm Infants
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 81